Two steps forward, one step back: Mycophenolate mofetil treatment for myasthenia gravis in the united states

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-4598|51|5|635-637

ISSN： 0148-639x

Source： MUSCLE AND NERVE, Vol.51, Iss.5, 2015-05, pp. : 635-637

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Can mycophenolate mofetil be tapered safely in myasthenia gravis? A retrospective, multicenter analysis

By  

MUSCLE AND NERVE, Vol. 52, Iss. 2, 2015-08 ,pp. : 211-215

John Wiley & Sons Inc

Access to resources Recommend Favorite

Two steps forward, one step back? A commentary on the disease-specific core sets of the International Classification of Functioning, Disability and Health (ICF)

By McIntyre Anne   Tempest Stephanie  

Disability and Rehabilitation, Vol. 29, Iss. 18, 2007-01 ,pp. : 1475-1479

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Mediastinal Fibrosis with Mycophenolate Mofetil

By  

Respiration, Vol. 78, Iss. 3, 2009-03 ,pp. : 330-333

Karger

Access to resources Recommend Favorite

Treatment of post-herpetic pain in myasthenia gravis: exacerbation of weakness due to gabapentin

By Scheschonka A.   Beuche W.  

Pain, Vol. 104, Iss. 1, 2003-07 ,pp. : 423-424

Elsevier

Access to resources Recommend Favorite

Low-dose tacrolimus treatment in thymectomised and steroid-dependent myasthenia gravis

By Kawaguchi Naoki   Yoshiyama Yasumasa   Nemoto Yuko   Munakata Shin   Fukutake Toshio   Hattori Takamichi  

Current Medical Research and Opinion, Vol. 20, Iss. 8, 2004-08 ,pp. : 1269-1273

Informa Healthcare

Access to resources Recommend Favorite